The present inventors have found that by administering the β-blocking drug to the surgical cycle of cancer patients, recurrence and / or metastasis after cancer surgery is suppressed. Accordingly, the present disclosure provides inhibitors for relapse and / or metastasis of cancer containing a β-blocking drug, which is administered in a cancer surgery cycle.
展开▼